Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05766787 · ClinicalTrials.gov registry record · NA
The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
A NA study of Refractive Ametropia, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 15
- Study locations
NCT05766787: Completed NA study of Refractive Ametropia, sponsored by Alcon Research.
NCT05766787 is a NA study of Refractive Ametropia that has completed, run by Alcon Research. The registered enrollment target is 190 participants, roughly in line with the 197-participant average among 5 other Refractive Ametropia trials with a reported enrollment target. The trial reports 15 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05766787, a NA study of Refractive Ametropia, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.
Primary Outcome
Visual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.
Conditions Studied
Interventions
- DEVICE Senofilcon A contact lenses
- DEVICE CLEAR CARE
- DEVICE Serafilcon A contact lenses
Study Locations (15)
Florida
- Omega Vision Center P.A. - Longwood
- Kindred Optics at Maitland Vision - Maitland
- Vision Health Institute - Orlando
- Tallahassee Eye Center - Tallahassee
California
- Kurata Eyecare Center - Los Angeles
- Dr. Elsa Pao, OD - Oakland
- Pacific Rims Optometry - San Francisco
Minnesota
- The Eye Doctors Inc - Eden Prairie
- Complete Eye Care of Medina - Medina
Tennessee
- Optometry Group, PLLC - Memphis
- Total Eye Care PA - Memphis
Kansas
- Heart of America Eye Care - Shawnee Mission
New York
- SUNY College of Optometry Clinical Vision Research Center - New York
Ohio
- ProCare Vision Centers, Inc. - Granville
Rhode Island
- West Bay Eye Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2023-06-02 |
| Phase | NA |
What the finished NCT05766787 record still lists
NCT05766787 is an interventional study that assigns participants to a tested intervention. The registered 190 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 197-participant average among 5 other Refractive Ametropia trials with a reported enrollment target.
The record links to 1 condition, with Refractive Ametropia appearing as the primary indexed condition, and to 3 interventions - of which Senofilcon A contact lenses is the first listed.
NCT05766787 lists 15 locations in 8 states (Florida, California, Minnesota).
Frequently Asked Questions
What is clinical trial NCT05766787 about?
NCT05766787 is a clinical study titled "The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses". The purpose of this study is to assess the clinical performance of two reusable silicone hydrogel contact lenses when worn on a daily wear basis.
What is the current status of trial NCT05766787?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2023-03-29. Estimated completion is 2023-06-02.
What conditions does trial NCT05766787 study?
This clinical trial studies the following conditions: Refractive Ametropia.
What interventions are being tested in trial NCT05766787?
The interventions under investigation include: Senofilcon A contact lenses (DEVICE), CLEAR CARE (DEVICE), Serafilcon A contact lenses (DEVICE).
Who is sponsoring clinical trial NCT05766787?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05766787 being conducted?
This trial has 15 study locations across California, Florida, Kansas, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Refractive Ametropia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparison of Two Daily Disposable Lenses
COMPLETED · NA
-
Clinical Evaluation of a Manufacturing Process for a Frequent Replacement Silicone Hydrogel Multifocal Contact Lens
COMPLETED · NA
-
Dispensing Evaluation of Subjective Comfort, Vision, and Handling of a New Lens Compared to a Marketed Lens
COMPLETED · NA
-
Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens
COMPLETED · NA
-
Air Optix Night and Day Aqua (AONDA) Retrospective Study 1
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03257033 · 190 participants · Phase 3
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
- NCT03642028 · 190 participants · Phase 4
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
- NCT04015609 · 190 participants · NA
Psychotherapy Intervention for Latinos With Advanced Cancer
- NCT04284397 · 190 participants · Early Phase 1
Identification of Critical Thermal Environments for Aged Adults
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI